ADMT: ADM Tronics Unlimited, Inc. Stock

by  •  • Comments Off on ADMT: ADM Tronics Unlimited, Inc. Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 4.93
Enterprise Value ($M) 4.90
Book Value ($M) 0.78
Book Value / Share 0.01
Price / Book 6.36
NCAV ($M) -0.12
NCAV / Share -0.00
Price / NCAV -42.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.39

Liquidity (mrq)
Quick Ratio 0.78
Current Ratio 1.21

Balance Sheet (mrq) ($M)
Current Assets 1.26
Assets 2.15
Liabilities 1.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
09-11 13G Margolin Marc Leslie 5.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐TRANSACTION REPORT
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐TRANSACTION REPOR
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐TRANSACTION REPORT PUR
2024-07-15 10-K FORM 10-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE

(click for more detail)

Similar Companies
ABMT – Advanced BioMedical Technologies, Inc. ADYX – Adynxx, Inc.
AFIB – Acutus Medical, Inc.


Financial data and stock pages provided by
Fintel.io